COVID-19: FDA Okays Blood Purification System to Reduce Inflammatories

FDA is authorizing the use of the Spectra Optia Apheresis System and Depuro D2000 Adsorption Cartridge devices to reduce the amount of cytokines and other inflammatory mediators in COVID-19 patients' blood.